For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
Bromodomain-containing protein 4 (BRD4) is a member of the Bromodomains and Extraterminal (BET) family, consisting of BRD2, BRD3, and BRDT. BRD4 is a transcription regulator consisting of two bromodomains which bind acetylated lysine residues on proteins, such as histones. In association with Cyclin T1 and CDK9, BRD4 forms a complex called P-TEFb which controls gene transcription. BRD4 is also involved in DNA damage response, embryogenesis, and cancer development. Inhibiting BRD4 is a strategy for treating cancer, and more recently targeting BRD4 with PROTAC molecules has emerged as a novel therapeutic approach.
The AlphaLISA SureFire Human Total BRD4 Detection Kit is a sandwich immunoassay for the quantitative detection of total BRD4 in cellular lysates, using Alpha Technology.
|Assay Points (200-50,000)||500 Assay Points|
|Experimental Type||In vitro|
|Product Brand Name||AlphaLISA SureFire Ultra|
|Shipping Condition||Blue Ice|
|Unit Size||500 Assay Points|
The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater ...
Product brochure for the Alpha Technology, a versatile, no wash, homogeneous assay technology that's suitable for a broad range of applications.
Find out about our range of integrated solutions for drug discovery screening in this e-brochure.
Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automat ...